Dr. Rebecca Laborde, Postdoctoral Research Fellow at Mayo Clinic in Rochester, MN, shares the results of a study...
» More
Dr. Rebecca Laborde, Postdoctoral Research Fellow at Mayo Clinic in Rochester, MN, shares the results of a study appearing in the March 2012 issue of Mayo Clinic Proceedings, that supports the application of mRNA-seq technology as a way to more accurately stratify patients based on individual tumor biology to improve the understanding of tumor prognosis and treatment responses which would improve individualized patient care strategies. Available at:
http://www.mayoclinicproceedings.org/article/S0025-6196(12)00124-3/fulltext
« Hide
